Zoetis (ZTS) Stock Price, Quote, News & History | Benzinga

Zoetis Inc (ZTS) Stock Price, Quote, News & History

ZTSNYSE

Trade with Public

Trade with Public

$77.25

0.150.19%

At close: Aug 31, 5:00 PM EST

$77.01

-0.0915-0.12%

Pre-Market: 8:17 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

-

Close

$77.25

Volume / Avg.

1.56K / 6.44M

Day Range

- - -

52 Wk Range

71.00 - 156.49

Market Cap

$31.82B

P/E Ratio

12.60

Dividend Yield

2.74%

Exchange

NYSE

RSI

54

Short Interest

4.6%

Days to Cover

1.95

Recent Zoetis Inc News

5 Stock Picks Last Week From Wall Street's Most Accurate Analysts

U.S. stocks close higher on Friday, with Nasdaq up 300 points and S&P 500 at record high. Benzinga's Analyst Ratings API can aid in stock picks.

Avi Kapoor

Zoetis Sees Softer Pet Health Demand, But Adapting Commercial Strategy to Navigate Headwinds

Zoetis beat second-quarter earnings estimates but missed on revenue, cut 2026 guidance and cited weaker pet health demand and pricing pressure.

Vandana Singh

Michael Burry Expands Bets Against Nvidia, Micron— and Is Now Buying Lululemon and DraftKings

Michael Burry expands short positions against Nvidia and AI, while piling into de-risked value stocks like Lululemon and DraftKings.

Rishabh Mishra

Zoetis' Acquisition of Neogen Genomics Business Faces Regulatory Scrutiny in Australia

The Australian agency is conducting a Phase 2 assessment of Zoetis' $160 million acquisition of Neogen's genomics unit due to competition concerns.

Vandana Singh

Jim Cramer Says He Feels 'Something Not Well' At Zoetis, Names A Rival As His Pick

Cramer says Zoetis has issues. Prefers this stock in animal health industry. Energy Transfer is in a good position.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

2.84B

Investing Cash Flow (TTM)

-720.00M

Financing Cash Flow (TTM)

-2.28B

Free Cash Flow (TTM)

2.32B

Capital Expenditure (TTM)

-524.00M

Net Change in Cash (TTM)

-162.00M

Analyst Trends and Forecast

1

1

Apr

2

1

May

1

Jun

2

2

Jul

4

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.4

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$39.49B

PE Ratio (TTM)

12.60

PE Ratio (FWD)

12.94

PEG Ratio (TTM)

7.19

PS Ratio (TTM)

3.49

PB Ratio (TTM)

10.14

Earnings Yield % (TTM)

7.94%

Earnings Yield % (FWD)

7.73%

EV / EBITDA (TTM)

9.82

Price / EBITDA (TTM)

8.28

Price / Free Cash Flow (TTM)

14.36

Book Value / Share

$7.62

Company Debt

Total Debt

$9.05B

LT Debt

$9.05B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$1.47B

Debt to Equity

2.93

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$77.25

Volume / Avg.

1.56K / 6.44M

Day Range

- - -

52 Wk Range

71.00 - 156.49

Market Cap

$31.82B

P/E Ratio

12.60

Dividend Yield

2.74%

Exchange

NYSE

RSI

54

Short Interest

4.6%

Days to Cover

1.95

About

Sector

Health Care

Industry

Pharmaceuticals

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (do...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Zoetis (ZTS) stock?

A

You can purchase shares of Zoetis (NYSE:ZTS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Zoetis (ZTS) competitors?

A

Other companies in Zoetis’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Zoetis (ZTS) stock?

A

Zoetis has a consensus price target of $137.78.

Q

What is the current price for Zoetis (ZTS)?

A

The stock price for Zoetis (NYSE: ZTS) is $77.0085 last updated September 2, 2026 at 12:21 AM EDT.

Q

Does Zoetis (ZTS) pay a dividend?

A

There are no upcoming dividends for Zoetis.

Q

When is Zoetis (NYSE:ZTS) reporting earnings?

A

Zoetis does not have any upcoming earnings scheduled.

Q

Is Zoetis (ZTS) going to split?

A

There is no upcoming split for Zoetis.

Q

What sector and industry does Zoetis (ZTS) operate in?

A

Zoetis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.